12:00 AM
Sep 24, 2012
 |  BC Week In Review  |  Company News  |  Deals

NeuroNova, Newron deal

Newron said it was unable to get the required two-thirds majority to vote in favor of its proposed acquisition of neurogenesis company NeuroNova. Newron said 66.32% of shares were voted in...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >